Understanding Low Testosterone in Men: What It Is, Why It Happens, and What You Can Do

Key Takeaways

• Low testosterone (hypogonadism) is common: the HIM Study found 38.7% prevalence in U.S. primary care men aged 45 and older.
• Symptoms often start subtle and include fatigue, low libido, reduced muscle mass, central weight gain, brain fog, and mood changes.
• Many men report meaningful symptoms at total testosterone levels below 750 ng/dL even when within the conventional 300 to 1,000 ng/dL reference range.
• Foundational support (sleep, weight, training, zinc, vitamin D, magnesium) is the first line for many men, particularly younger patients.
• When TRT is appropriate, VIMC offers fertility-preserving alternatives including clomiphene, hCG, gonadorelin, and peptides for men who want to maintain reproductive capacity.

Men do not always notice low testosterone arriving. It tends to creep in: a little less energy, a little less drive, a body that no longer responds to training the way it used to, sleep that does not restore, a mood that feels off without an obvious reason. Many men chalk these changes up to stress, age, or simply the cost of getting older. Often the real explanation is hormonal, measurable, and treatable.

Low testosterone, clinically known as hypogonadism, is more common than most men realize. The HIM Study of more than 2,000 men aged 45 and older in U.S. primary care practices found a hypogonadism prevalence of 38.7%, with significantly elevated rates in men with diabetes, obesity, and hypertension (Mulligan et al., International Journal of Clinical Practice, 2006). At Venus Integrative Medical Center (VIMC) in Mesa, Arizona, the team takes low testosterone seriously as a clinical condition with real downstream effects on metabolic, cognitive, and emotional health, and approaches it through the lens of root-cause evaluation rather than symptom management alone.

What Low Testosterone Actually Is

Testosterone production is regulated by a feedback loop between the brain and the testes. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which prompts the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH tells the testes to make testosterone; FSH supports sperm production. When circulating testosterone is adequate, the brain dials its signal down. When the system breaks anywhere along this chain, testosterone falls.

Hypogonadism is generally divided into two categories. Primary hypogonadism means the testes themselves are not producing adequately despite a normal brain signal. Secondary hypogonadism means the brain signal to the testes is impaired, often by sleep deprivation, opioid medications, pituitary issues, obesity-related metabolic disruption, or chronic illness. Distinguishing between the two is part of a complete workup because the upstream cause changes what the right treatment looks like.

Recognizing the Signs and Symptoms

Symptoms of low testosterone often start subtle and intensify gradually. Many men only connect the dots after a comprehensive lab evaluation.

Physical signs

• Persistent fatigue and low daily energy even with adequate sleep.
• Loss of muscle mass and strength, particularly with reduced response to training.
• Increased body fat, especially around the abdomen.
• Reduced bone density or unexpected fractures.
• Hair thinning on the body or face.

Sexual signs

• Reduced libido or sexual interest.
• Erectile changes, including reduced quality or fewer spontaneous erections.
• Decreased semen volume and potential fertility changes.

Mental and emotional signs

• Brain fog and difficulty concentrating.
• Low motivation or drive, even for activities previously enjoyed.
• Irritability or low mood that does not respond to lifestyle changes.

What Actually Drives Low Testosterone

Low testosterone rarely has a single cause. More often it is a combination of factors that compound over years.

Age-related decline

Testosterone peaks in late adolescence and early adulthood, then declines gradually with age. Longitudinal data from the Massachusetts Male Aging Study established that within-person testosterone declines on the order of 1% per year in adult men, with steeper drops in bioavailable testosterone (Feldman et al., Journal of Clinical Endocrinology & Metabolism, 2002). This pattern is sometimes referred to colloquially as “andropause” or “male menopause,” though late-onset hypogonadism is the clinically accurate term and the decline is more gradual than the abrupt hormonal shift women experience at menopause.

Metabolic and body composition factors

Obesity is one of the strongest modifiable drivers. Adipose tissue contains the aromatase enzyme, which converts testosterone into estrogen, lowering circulating testosterone and altering downstream signaling. Type 2 diabetes, insulin resistance, and metabolic syndrome are independently and consistently associated with lower testosterone in observational data.

Sleep, stress, and lifestyle

Sleep is one of the most underappreciated drivers. A landmark JAMA study by Leproult and Van Cauter (2011) found that one week of sleep restricted to five hours per night reduced daytime testosterone in healthy young men by an average of 10 to 15 percent. Chronic stress and elevated cortisol suppress hypothalamic signaling. Heavy alcohol use, smoking, and a fully sedentary pattern all push testosterone in the same direction.

Medications and medical conditions

Opioids are a major culprit and are often missed. Chronic glucocorticoid use, certain antidepressants, anti-androgen medications, and some chemotherapy agents can lower testosterone. Thyroid dysfunction, pituitary issues, kidney and liver disease, and chronic systemic illness all merit evaluation as part of a thorough workup.

How Low Testosterone Is Properly Diagnosed

Accurate diagnosis matters. Testosterone fluctuates throughout the day, peaks in the morning, and varies meaningfully even within an individual man across days. A single low reading is not a diagnosis. The minimum standard for evaluation is two fasting morning blood tests on separate days, drawn before 10 a.m. when testosterone is naturally at its highest.

A complete workup looks beyond total testosterone. Free testosterone (the unbound, biologically active fraction), sex hormone-binding globulin (SHBG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) all add meaningful information about where the system is failing. Estradiol, estrone, thyroid function, prolactin, complete metabolic panel, and complete blood count round out the picture. At VIMC, this comprehensive workup is the starting point rather than something added when initial labs are ambiguous.

Normal Versus Optimal: A Different Way to Think About Testosterone

Most labs in the United States use a total testosterone reference range of roughly 300 to 1,000 ng/dL. A 2022 Journal of Urology analysis by Zhu and colleagues, using NHANES data, refined age-specific cutoffs and argued that the conventional 300 ng/dL lower limit is too low for many men, particularly younger men. At VIMC, the clinical position is that many men report meaningful symptoms at total testosterone levels below 750 ng/dL even within the conventional "normal" range. The decision to pursue TRT or hormone optimization rests on individual clinical assessment, not a single lab number.

A reference range describes the statistical distribution of a population that includes unhealthy men, sedentary men, obese men, and men with undiagnosed metabolic disease. It is not a description of the testosterone level at which a healthy man feels and functions well. Symptom-emergence research (Zitzmann et al., 2006, JCEM; Wu et al., 2010, EMAS) shows that libido, mood, and metabolic symptoms can appear at different testosterone levels across individuals, which is why VIMC emphasizes symptom-driven evaluation alongside lab values rather than fixed cutoffs.

Treatment Options: From Foundation to Therapy

Foundational Support: The First Line for Many Men

For men with mild to moderate symptoms, borderline labs, or correctable contributing factors, foundational lifestyle and nutritional support is the right starting place. Many men see meaningful testosterone gains from addressing root drivers before any prescription is considered.

Sleep is the highest-leverage area. Seven to nine hours of consistent, quality sleep is non-negotiable. Body composition matters profoundly: weight loss in men with obesity has been shown to raise testosterone meaningfully, often by amounts comparable to mild TRT effects. Resistance training and high-intensity interval training both support endogenous production, more reliably than steady-state cardio alone.

Targeted nutritional support fills common gaps. Zinc deficiency has been linked to reduced testosterone production and is widespread in men with marginal diets. Vitamin D, often deficient in midlife men, supports both testosterone and overall metabolic health. Magnesium aids sleep, stress regulation, and androgen function. Alcohol reduction and smoking cessation produce measurable hormonal benefits in their own right.

For some men, lifestyle work alone is enough. For others, it is the foundation that makes any subsequent therapy more effective and sustainable.

When TRT Becomes the Right Conversation

When symptoms persist after foundational work, or when the clinical picture is severe enough to warrant earlier intervention, testosterone replacement therapy is a well-established option. The 2023 TRAVERSE trial settled the long-standing cardiovascular safety question for properly screened patients, and modern TRT is delivered through customized bioidentical formulations and monitored carefully. The VIMC Is Testosterone Replacement Therapy Safe for Men? post covers the current safety evidence, delivery methods, and the prostate cancer reframing in detail.

Fertility-Preserving Alternatives

Exogenous testosterone suppresses the brain’s signal to the testes, which reduces sperm production. For men who want to preserve fertility, exogenous TRT is not the only option. Clomiphene citrate and human chorionic gonadotropin (hCG) stimulate the body’s own testosterone production while preserving spermatogenesis. Certain FDA-approved peptides can also be appropriate adjuncts depending on the clinical picture. These options are part of every VIMC male hormone evaluation when fertility intentions are part of the conversation, not added on after the fact.

How the VIMC Team Approaches Low Testosterone

Low testosterone is rarely just a number on a lab report; it is the visible end of a longer chain of inputs. The VIMC approach to male hormone care is built on root-cause evaluation rather than reflexive prescribing. The first visit looks for the upstream drivers: sleep architecture, metabolic health, body composition, thyroid and adrenal function, medication exposure, stress patterns, and nutritional status. When these factors are addressed alongside any hormone therapy, results are more durable and the dose required to achieve the same clinical outcome is often lower.

Age is treated as a clinical guide, not a categorical limit at VIMC. Younger men in their 30s and older men in their 60s and beyond can each be appropriate candidates for evaluation and, when indicated, treatment. The overt contraindications for testosterone therapy remain specific: active prostate cancer, severe untreated polycythemia, severe untreated obstructive sleep apnea, and active severe cardiovascular disease.

Ready to Find the Root Cause?

If the symptoms in this post sound familiar, the next step is a thorough evaluation rather than guessing at the cause. The VIMC team in Mesa, Arizona provides comprehensive male hormone evaluations for men across Mesa, Scottsdale, Chandler, Gilbert, and the greater East Valley designed to find what is actually driving the picture, not just confirm a low number.